IP Library Granted Patent US 9,945,650
Granted Patent B2
US 9,945,650 · App. 15/193,801 · Granted Apr 17, 2018

Biological active bullets, systems, and methods

Inventor: Darren Rubin (Largo, FL)
F42B12/54F42B12/72
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,945,650
App. No.
15/193,801
Granted
Apr 17, 2018
Kind
B2
Abstract

A hemostatic bullet projectile is for discharge from a firearm and for use as a weapon. The ammunition is a bullet in a cartridge. The bullet projectile includes, and is distinguished by, the use of at least one potentially biological active substance delivered to a bullet wound of a target and serving as a hemostatic agent to promote blood clotting and/or control hemorrhage in the bullet would to stabilize the target until surgery can be performed. Methods are included to promote blood clotting and/or control hemorrhage in at least one bullet wound by delivery of a hemostatic agent by the bullet projectile causing the wound as well as minimizing the risk of embolism from the hemostatic bullet projectile.

Claims (2)

1. A method of promoting blood clotting and or controlling hemorrhage in at least one bullet wound;

said method including the steps of aiming a firearm at a human target and discharging from said firearm a bullet projectile associated with at least one hemostatic agent, and making said at least one hemostatic agent immediately available to interact with blood in said at least one bullet wound of said human target, while minimizing the risk of causing an embolism in said target.

Continuity (3)
Continuation In Part 14615671 · Feb 6, 2015
Continuation In Part 13461863 · May 2, 2012
Related Publication 20160298947A1 · Oct 13, 2016